CountryFocus: Healthcare, Regulatory and Reimbursement Landscape – Turkey

Publisher Name:
Published Date: 13-Jul-2016
No. of pages: 243

GlobalData, the industry analysis specialist, has released its latest report, “CountryFocus: Healthcare, Regulatory and Reimbursement Landscape – Turkey”. The report is an essential source of information on and analysis of the healthcare, regulatory and reimbursement landscape in Turkey. It identifies the key trends in the country’s healthcare market and provides insights into its demographic, regulatory, and reimbursement landscape and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of its pharmaceutical and medical device markets. It uses data and information sourced from proprietary databases, secondary research, and in-house analysis by GlobalData’s team of industry experts.

Turkey’s population stood at approximately 78.74 million in 2015, and is increasing due to a positive balance between the birth and the death rates, as well as longer life expetancy. The pharmaceutical market was estimated at $4.91 billion in 2015, and is expected to reach approximately $5.43 billion by 2020 at a Compound Annual Growth Rate (CAGR) of 2% due to health transformation Program. The medical devices market was estimated approximately $1.59 billion in 2015 and is expected to reach $2.05 billion by 2020, at a CAGR of 4.2%.

The increase in Turkey”s phamraceutical market can primarily be attribtued to –

  • Improved medical access
  • Decline in average price level of the pharmaceuticals
  • Increase in the number of pharmaceutical companies

Scope

The report provides information on Turkey’s healthcare, regulatory and reimbursement landscape, and includes –

  • An overview of the pharmaceutical and medical devices markets, comprising size, segmentation and key drivers and barriers
  • Profiles and SWOT analyses of the major players in the pharmaceutical and medical devices market. The major players covered for the pharmaceutical market are Abdi Ibrahim, Novartis, Pfizer, Sanofi and Bayer. The major players covered for the medical devices market are Baxter, Alcon, Essilor, Fresenius Medical Care and Johnson & Johnson Vision care
  • An insightful review of the country’s reimbursement and regulatory landscape, including details of the healthcare reimbursement process, regulatory agencies and approval processes for new drugs
  • Detailed analysis of the political and economic environment, including economic indicators, demographics, and healthcare infrastructure and expenditure
  • An overview of the opportunities for and challenges to growth in the healthcare market

Reasons to buy

This report will enhance your decision-making capability by allowing you to –

  • Develop business strategies by understanding the trends shaping and driving Turkey’s healthcare market
  • Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments and companies likely to impact Turkey’s healthcare market in the future
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing competitors’ performance
  • Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment and strategic partnership

Table of Contents For This Report

Table of Contents

1 Table of Contents 7

1.1 List of Tables 10

1.2 List of Figures 14

2 Introduction 18

3 Overview of Pharmaceutical and Medical Device Markets 19

3.1 Pharmaceutical Market 19

3.1.1 Market Overview 19

3.1.2 Pharmaceutical Import and Export 21

3.1.3 Supply Channels 23

3.1.4 Market Segments 24

3.1.5 Major Therapeutic Areas 27

3.1.6 Major Companies 30

3.2 Medical Device Market 74

3.2.1 Market Overview 74

3.2.2 Overview of Top Five Segments 76

3.2.3 Major Players 85

3.3 Market Drivers and Barriers 119

3.3.1 Drivers 119

3.3.2 Barriers 121

4 Market Access 123

4.1 Reimbursement and Payer Landscape 123

4.1.1 Overview of Healthcare System 123

4.1.2 Reimbursement Process 129

4.1.3 Overview of Insurance Providers 131

4.1.4 Patient Share of Healthcare Expenditure 133

4.1.5 Healthcare Price Trends 134

4.1.6 Pricing Policies 135

4.2 Regulatory Landscape 136

4.2.1 Overview of Regulatory Agencies 136

4.2.2 Market Authorization Procedure for Pharmaceutical Products 137

4.2.3 New Medical Device Approval Process 139

4.2.4 Licensing Process for Pharmaceutical and Medical Device Manufacturing 142

4.2.5 Licensing Process for Pharmaceutical Exports and Imports 143

4.2.6 Intellectual Property Rights 144

4.2.7 Clinical Trial Regulations 146

4.2.8 Pharmaceutical Advertising Regulations 148

4.2.9 Pharmacy Regulations 149

4.2.10 Labeling and Packaging Regulations 150

5 Country Analysis 152

5.1 Political Environment 152

5.1.1 Political Structure 152

5.1.2 Analysis of the Current Political Environment 154

5.1.3 Healthcare Policy Initiatives 156

5.2 Economic Landscape 158

5.3 Economic Indicators 159

5.3.1 Gross Domestic Product 159

5.3.2 Gross National Income 163

5.3.3 Inflation 164

5.3.4 Currency Exchange Rate 168

5.3.5 Foreign Direct Investment 169

5.3.6 Foreign Exchange Reserves 170

5.3.7 Trade Balance 171

5.3.8 Government Structural Balance 173

5.3.9 Government Net Debt 175

5.3.10 Major Industries 176

5.4 Demographics 178

5.4.1 Population 178

5.4.2 Education and Literacy 193

5.4.3 Employment 195

5.4.4 Disease Burden 196

5.5 Healthcare Infrastructure 197

5.5.2 Healthcare Parameters 200

5.5.3 Environmental Health 202

5.5.4 Healthcare Personnel 208

5.6 Healthcare Expenditure 212

5.6.1 Overview of Healthcare Expenditure 212

5.6.2 Major Components of Healthcare Expenditure 213

5.6.3 Healthcare Expenditure Distribution 214

5.6.4 Spending in Pharmaceutical R&D 215

5.7 Trade Associations 216

5.7.1 Turkish Pharmacists’ Association 216

5.7.2 Pharmaceutical Manufacturer’s Association of Turkey 217

5.7.3 Turkish Confederation of Employer Associations 217

5.8 Trade Fairs 218

6 Opportunities and Challenges 219

6.1 Opportunities 219

6.2 Challenges 220

7 Appendix 223

7.1 Abbreviations 223

7.2 Bibliography 226

7.3 Research Methodology 240

7.3.1 Coverage 240

7.3.2 Secondary Research 240

7.3.3 Forecasts 241

7.3.4 Expert Panel 241

7.4 Disclaimer 242

List of Tables

Table 1: Pharmaceutical Market, Turkey, Revenue ($bn), 2008-2015 21

Table 2: Pharmaceutical Market, Turkey, Revenue ($bn), 2016-2020 21

Table 3: Pharmaceutical Market, Turkey, Imports and Exports ($bn), 2008-2015 23

Table 4: Generic Market, Turkey, Revenue ($bn), 2008-2015 25

Table 5: OTC Market, Turkey, Revenue ($bn), 2008-2015 27

Table 6: Pharmaceutical Market, Turkey, Major Therapeutic Areas by Value (%), 2015 28

Table 7: Pharmaceutical Market, Abdi Ibrahim, Major Products, 2016 31

Table 8: Pharmaceutical Market, Novartis, Major Products, 2016 36

Table 9: Pharmaceutical Market, Novartis, Global, Planned Filings, 2015 37

Table 10: Pharmaceutical Market, Pfizer, Global, Major Products, 2015 46

Table 11: Pharmaceutical Market, Pfizer, Global, Planned Filings, 2015 47

Table 12: Pharmaceutical Market, Sanofi, Global, Planned Filings, 2015 56

Table 13: Pharmaceutical Market, Bayer, Major Marketed Products, 2015 62

Table 14: Pharmaceutical Market, Bayer, Pipeline Products, 2015 66

Table 15: Medical Device Market, Turkey, Revenue ($bn), 2008-2015 74

Table 16: Medical Device Market, Turkey, Revenue ($bn), 2016-2020 75

Table 17: Medical Device Market, Turkey, Major Players by Revenue ($m) and Share (%), 2015 76

Table 18: Ophthalmic Device Market, Turkey, Revenue ($m), 2008-2015 77

Table 19: Ophthalmic Device Market, Turkey, Major Players by Revenue ($m) and Market Share (%), 2012 78

Table 20: Nephrology and Urology Diagnostics Device Market, Turkey, Revenue ($m), 2008-2015 79

Table 21: Nephrology and Urology Diagnostics Device Market, Turkey, Major Players by Revenue ($m) and Share (%), 2012 80

Table 22: Orthopedic Device Market, Turkey, Revenue ($m), 2008-2015 81

Table 23: Orthopedics Device Market, Turkey, Major Players by Revenue ($m) and Share (%), 2015 81

Table 24: Drug Delivery Device Market, Turkey, Revenue ($m), 2008-2015 82

Table 25: Drug Delivery Device Market, Turkey, Major Players by Revenue ($m) and Share (%), 2012 83

Table 26: Diabetes Care Device Market, Turkey, Revenue ($m), 2008-2015 84

Table 27: Diabetes Care Device Market, Turkey, Major Players by Revenue ($m) and Share (%), 2012 85

Table 28: Medical Device Market, Turkey, Revenue by Leading Companies ($m), 2012 86

Table 29: Baxter, Global, Major Products, 2016 87

Table 30: Major Products, Alcon, Major Products, 2015 96

Table 31: Fresenius Medical Care, Major Products, 2015 103

Table 32: Johnson & Johnson, Global, Major Products, 2016 110

Table 33: Healthcare Spending, Turkey, Patient Share (%), 2008-2015 133

Table 34: Healthcare Industry, Turkey, Price Change (%), 2008-2014 134

Table 35: Economic Indicators, Turkey, Gross Domestic Product per Capita ($), 2008-2015 160

Table 36: Economic Indicators, Turkey, Gross Domestic Product per Capita ($), 2016-2020 161

Table 37: Economic Indicators, Turkey, Gross Domestic Product Annual Growth (%), 2008-2015 162

Table 38: Economic Indicators, Turkey, Gross Domestic Product Annual Growth (%), 2016-2020 163

Table 39: Economic Indicators, Turkey, Gross National Income per Capita ($), 2008-2014 164

Table 40: Economic Indicators, Turkey, Consumer Price Index, 2008-2015 165

Table 41: Economic Indicators, Turkey, Consumer Price Index, 2016-2020 166

Table 42: Economic Indicators, Turkey, Average Annual Consumer Price Change (%), 2008-2015 167

Table 43: Economic Indicators, Turkey, Average Annual Consumer Price Change (%), 2016-2020 168

Table 44: Economic Indicators, Turkey, Currency Exchange Rate (TL/$), 2008-2015 169

Table 45: Economic Indicators, Turkey, Foreign Direct Investment ($bn), 2008-2014 170

Table 46: Economic Indicators, Turkey, Foreign Exchange Reserves ($bn), 2008-2014 171

Table 47: Economic Indicators, Turkey, Imports ($bn), 2008-2014 172

Table 48: Economic Indicators, Turkey, Exports ($bn), 2008-2014 173

Table 49: Economic Indicators, Turkey, Government Structural Balance ($bn), 2008-2015 174

Table 50: Economic Indicators, Turkey, Government Net Debt ($bn), 2008-2015 175

Table 51: Economic Indicators, Turkey, Government Net Debt ($bn), 2016-2020 176

Table 52: Economic Indicators, Turkey, Major Industries by Hours Worked Index, 2014 177

Table 53: Demographics, Turkey, Population (million), 2008-2015 178

Table 54: Demographics, Turkey, Population (million), 2016-2020 179

Table 55: Demographics, Turkey, Urban-Rural Population Share (%), 2008-2015 180

Table 56: Demographics, Turkey, Urban-Rural Population Share (%), 2016-2020 181

Table 57: Demographics, Turkey, Population Distribution by Age Group (%), 2008-2015 182

Table 58: Demographics, Turkey, Population Distribution by Age Group (%), 2016-2020 183

Table 59: Demographics, Turkey, Births (per 1,000 population), 2008-2015 184

Table 60: Demographics, Turkey, Mortality (per 1,000 population), 2008-2015 185

Table 61: Demographics, Turkey, Causes of Mortality (%), 2015 186

Table 62: Demographics, Turkey, Infant Mortality Rate (per 1,000 live births), 2008-2015 187

Table 63: Demographics, Turkey, Immunization Rate (%), 2008-2015 188

Table 64: Demographics, Turkey, Male Mortality Rate (%), 2014 189

Table 65: Demographics, Turkey, Female Mortality Rate (%), 2014 190

Table 66: Demographics, Turkey, Gender Ratio (M/F), 2008-2014 191

Table 67: Demographics, Turkey, Life Expectancy at Birth (years), 2008-2015 192

Table 68: Demographics, Turkey, Literacy by Age Group (%), 2014 194

Table 69: Demographics, Turkey, Unemployment Rate (%), 2008-2015 196

Table 70: Demographics, Turkey, Disability-Adjusted Life Years (per 1,000 population), 2009 197

Table 71: Healthcare Infrastructure, Turkey, Public and Private Hospitals, 2008-2015 198

Table 72: Healthcare Infrastructure, Turkey, Diagnostic Units (per 100,000 population), 2008-2015 199

Table 73: Healthcare Infrastructure, Turkey, Beds (per 1,000 population), 2008-2015 200

Table 74: Healthcare Parameters, Turkey, Beds by Type of Care (per 1,000 population), 2008-2015 201

Table 75: Healthcare Infrastructure, Turkey, Doctors (per 1,000 population), 2008-2015 202

Table 76: Demographics, Turkey, Water Pollution Sources (thousand m3/year), 2014 204

Table 77: Environmental Health, Turkey, CO2 Emissions (million tons), 2008-2015 205

Table 78: Environmental Health, Turkey, NOx Emissions (thousand tons), 2008-2015 206

Table 79: Environmental Health, Turkey, SOx Emissions (thousand tons), 2008-2015 207

Table 80: Environmental Health, Turkey, PM2.5 Emissions (µg/m3), 2008-2015 208

Table 81: Healthcare Personnel, Turkey, Nurses (per 100,000 population), 2008-2015 209

Table 82: Healthcare Personnel, Turkey, Pharmacists (per 100,000 population), 2008-2015 210

Table 83: Healthcare Personnel, Turkey, Dentists (per 100,000 population), 2008-2015 211

Table 84: Healthcare Expenditure, Turkey, Healthcare Expenditure (% of GDP), 2008-2015 212

Table 85: Healthcare Expenditure, Turkey, Share of Major Components (%), 2014 214

Table 86: Healthcare Expenditure, Turkey, Public-Private Share of Healthcare Expenditure ($ per capita), 2008-2015 215

Table 87: Healthcare Expenditure, Turkey, Public-Private Share of Healthcare Expenditure (% of GDP), 2008-2015 216

Table 88: Major Healthcare Trade Fairs, Turkey, 2016-2017 218

List of Figures

Figure 1: Pharmaceutical Market, Turkey, Revenue ($bn), 2008-2015 20

Figure 2: Pharmaceutical Market, Turkey, Revenue ($bn), 2016-2020 21

Figure 3: Pharmaceutical Market, Turkey, Imports and Exports ($bn), 2008-2015 23

Figure 4: Generic Market, Turkey, Revenue ($bn), 2008-2015 25

Figure 5: OTC Market, Turkey, Revenue ($bn), 2008-2015 26

Figure 6: Pharmaceutical Market, Turkey, Major Therapeutic Areas by Value (%), 2015 27

Figure 7: Medical Device Market, Turkey, Revenue ($bn), 2008-2015 74

Figure 8: Medical Device Market, Turkey, Revenue ($bn), 2016-2020 75

Figure 9: Medical Device Market, Turkey, Revenue by Segment ($m), 2015 76

Figure 10: Ophthalmic Device Market, Turkey, Revenue ($m), 2008-2015 77

Figure 11: Ophthalmic Device Market, Turkey, Major Players by Share (%), 2012 78

Figure 12: Nephrology and Urology Diagnostics Device Market, Turkey, Revenue ($m), 2008-2015 79

Figure 13: Nephrology and Urology Diagnostics Device Market, Turkey, Major Players by Share (%), 2012 79

Figure 14: Orthopedic Device Market, Turkey, Revenue ($m), 2008-2015 80

Figure 15: Orthopedics Device Market, Turkey, Major Players by Share (%), 2015 81

Figure 16: Drug Delivery Device Market, Turkey, Revenue ($m), 2008-2015 82

Figure 17: Drug Delivery Device Market, Turkey, Major Players by Share (%), 2012 83

Figure 18: Diabetes Care Device Market, Turkey, Revenue ($m), 2008-2015 84

Figure 19: Diabetes Care Device Market, Turkey, Major Players by Share (%), 2012 84

Figure 20: Medical Device Market, Turkey, Revenue by Leading Companies ($m), 2012 85

Figure 21: Healthcare Market, Turkey, Drivers and Barriers, 2016 122

Figure 22: Chronology of the Republican Era of Medicine and Pharmacy Management, Turkey, 2016 126

Figure 23: Strategic Planning Management, Turkey, 2016 127

Figure 24: Organizational Structure of Ministry of Health, Turkey, 2016 128

Figure 25: Drug Reimbursement Approval Process, Turkey, 2015 130

Figure 26: Healthcare Spending, Turkey, Patient Share (%), 2008-2015 133

Figure 27: Healthcare Industry, Turkey, Price Change (%), 2008-2014 134

Figure 28: Organizational Structure of Ministry of Health, Turkey, 2016 136

Figure 29: Major Health Reforms, Turkey, 2008-2015 157

Figure 30: Economic Indicators, Turkey, Gross Domestic Product per Capita ($), 2008-2015 160

Figure 31: Economic Indicators, Turkey, Gross Domestic Product per Capita ($), 2016-2020 161

Figure 32: Economic Indicators, Turkey, Gross Domestic Product Annual Growth (%), 2008-2015 162

Figure 33: Economic Indicators, Turkey, Gross Domestic Product Annual Growth (%), 2016-2020 163

Figure 34: Economic Indicators, Turkey, Gross National Income per Capita ($), 2008-2014 164

Figure 35: Economic Indicators, Turkey, Consumer Price Index, 2008-2015 165

Figure 36: Economic Indicators, Turkey, Consumer Price Index, 2016-2020 166

Figure 37: Economic Indicators, Turkey, Average Annual Consumer Price Change (%), 2008-2015 167

Figure 38: Economic Indicators, Turkey, Average Annual Consumer Price Change (%), 2016-2020 168

Figure 39: Economic Indicators, Turkey, Currency Exchange Rate (TL/$), 2008-2015 169

Figure 40: Economic Indicators, Turkey, Foreign Direct Investment ($bn), 2008-2014 170

Figure 41: Economic Indicators, Turkey, Foreign Exchange Reserves ($bn), 2008-2014 171

Figure 42: Economic Indicators, Turkey, Imports ($bn), 2008-2014 172

Figure 43: Economic Indicators, Turkey, Exports ($bn), 2008-2014 173

Figure 44: Economic Indicators, Turkey, Government Structural Balance ($bn), 2008-2015 174

Figure 45: Economic Indicators, Turkey, Government Net Debt ($bn), 2008-2015 175

Figure 46: Economic Indicators, Turkey, Government Net Debt ($bn), 2016-2020 176

Figure 47: Economic Indicators, Turkey, Major Industries by Hours Worked Index, 2014 177

Figure 48: Demographics, Turkey, Population (million), 2008-2015 178

Figure 49: Demographics, Turkey, Population (million), 2016-2020 179

Figure 50: Demographics, Turkey, Urban-Rural Population Share (%), 2008-2015 180

Figure 51: Demographics, Turkey, Urban-Rural Population Share (%), 2016-2020 181

Figure 52: Demographics, Turkey, Population Distribution by Age Group (%), 2008-2015 182

Figure 53: Demographics, Turkey, Population Distribution by Age Group (%), 2016-2020 183

Figure 54: Demographics, Turkey, Births (per 1,000 population), 2008-2015 184

Figure 55: Demographics, Turkey, Mortality (per 1,000 population), 2008-2015 185

Figure 56: Demographics, Turkey, Causes of Mortality (%), 2015 186

Figure 57: Demographics, Turkey, Infant Mortality Rate (per 1,000 live births), 2008-2015 187

Figure 58: Demographics, Turkey, Immunization Rate (%), 2008-2015 188

Figure 59: Demographics, Turkey, Male Mortality Rate (%), 2014 189

Figure 60: Demographics, Turkey, Female Mortality Rate (%), 2014 190

Figure 61: Demographics, Turkey, Gender Ratio (M/F), 2008-2015 191

Figure 62: Demographics, Turkey, Life Expectancy at Birth (years), 2008-2015 192

Figure 63: Demographics, Turkey, Literacy by Age Group (%), 2014 194

Figure 64: Demographics, Turkey, Unemployment Rate (%), 2008-2015 195

Figure 65: Demographics, Turkey, Disability-Adjusted Life Years (per 1,000 population), 2009 196

Figure 66: Healthcare Infrastructure, Turkey, Public and Private Hospitals, 2008-2015 198

Figure 67: Healthcare Infrastructure, Turkey, Diagnostic Units (per 100,000 population), 2008-2015 199

Figure 68: Healthcare Infrastructure, Turkey, Beds (per 1,000 population), 2008-2015 200

Figure 69: Healthcare Parameters, Turkey, Beds by Type of Care (per 1,000 population), 2008-2015 201

Figure 70: Healthcare Infrastructure, Turkey, Doctors (per 1,000 population), 2008-2015 202

Figure 71: Demographics, Turkey, Sources of Water Pollution (thousand m3/year), 2014 203

Figure 72: Environmental Health, Turkey, CO2 Emissions (million tons), 2008-2015 205

Figure 73: Environmental Health, Turkey, NOx Emissions (thousand tons), 2008-2015 206

Figure 74: Environmental Health, Turkey, SOx Emissions (thousand tons), 2008-2015 207

Figure 75: Environmental Health, Turkey, PM2.5 Emissions (µg/m3), 2008-2015 208

Figure 76: Healthcare Personnel, Turkey, Nurses (per 100,000 population), 2008-2015 209

Figure 77: Healthcare Personnel, Turkey, Pharmacists (per 100,000 population), 2008-2015 210

Figure 78: Healthcare Personnel, Turkey, Dentists (per 100,000 population), 2008-2015 211

Figure 79: Healthcare Expenditure, Turkey, Healthcare Expenditure (% of GDP), 2008-2015 212

Figure 80: Healthcare Expenditure, Turkey, Share of Major Components (%), 2014 213

Figure 81: Healthcare Expenditure, Turkey, Public-Private Share of Healthcare Expenditure ($ per capita), 2008-2015 215

Figure 82: Healthcare Expenditure, Turkey, Pharmaceutical R&D Expenditure (% of GDP), 2008-2015 216

Figure 83: Healthcare Market, Turkey, Opportunities and Challenges, 2016 222

Get Updates

Share This Post

Latest Reports from Life Sciences category

© 2016 Market optimizer. All rights reserved.